Search Results 51-60 of 22894 for Lateral
Amyotrophic lateral sclerosis (a-my-o-TROE-fik LAT-ur-ul skluh-ROE-sis), or ALS, is a progressive nervous system (neurological) disease that destroys nerve ...
Radicava® (Edaravone) Biomarker Study in Participants with Amyotrophic Lateral Sclerosis · Overview · Participation eligibility · Participating Mayo Clinic ...
The purpose of this study is to evaluate and rank-order a set of new outcome measures administered to patients with amyotrophic lateral sclerosis (ALS), in ...
Areas of focus: Primary lateral sclerosis, Muscular dystrophy, Myasthenia gravis, Amyotrophic lateral sclerosis, Mitochondrial disease,... Motor neuron ...
Immune Phenotyping in Amyotrophic Lateral Sclerosis. Rochester, Minn. The goals of this study are to identify biomarkers that allow improved staging or ...
Amyotrophic lateral sclerosis (ALS). Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...
Rare subtypes of frontotemporal dementia cause movements similar to those seen in Parkinson's disease or amyotrophic lateral sclerosis (ALS). Movement ...
Lateral decubitus DSM is part of Mayo Clinic's new imaging protocol for patients who present with spontaneous intracranial hypotension. That protocol starts ...
A Study to Evaluate Efficacy, Safety and Tolerability of CK-2127107 in Patients With Amyotrophic Lateral Sclerosis (ALS) · Share · Facebook · Twitter.
Bjorn E. Oskarsson, M.D.. Jacksonville, FL. Area of Focus: Lumbar puncture, Primary lateral sclerosis, Amyotrophic lateral sclerosis, Motor neuron disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.